Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec Ixo-vec, a single ...

CLIN1-17090 Development of a novel intravitreal AAV gene therapy for the rare disease blue cone monochromacy Aaron Nagiel – Blue Gen Therapeutics Foundation $4,691,936 Through the $4.7 million award, ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Adverum Biotechnologies, Inc. before investing. In this article, we go over a few ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

The Winnipeg Blue Bombers are mourning the death of a family member of one of their all-time legends. The Bombers revealed on Monday night that the oldest son of hall of famer Milt Stegall ...

Blue Origin's next suborbital flight is scheduled to launch on Saturday (May 31), carrying a diverse crew of educators, entrepreneurs and adventurers united by a shared passion for space and ...

When José Berríos is at his best, you barely notice him. Story on the man who quietly and consistently keeps giving the #BlueJays “exactly what we needed ...